Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec 14:12:792960.
doi: 10.3389/fpsyt.2021.792960. eCollection 2021.

Emotional Blunting in Patients With Major Depressive Disorder: A Brief Non-systematic Review of Current Research

Affiliations
Review

Emotional Blunting in Patients With Major Depressive Disorder: A Brief Non-systematic Review of Current Research

Hongzhe Ma et al. Front Psychiatry. .

Abstract

Emotional blunting is frequently reported by patients with major depressive disorder (MDD) and has been identified as one of the most prominent side effects of antidepressants leading to medication discontinuation. However, antidepressant-induced emotional blunting remains largely unexplored-there lacks a clinical definition of this condition, and no agreeing conclusion has been reached regarding its etiology. Current research suggests that the onset of diminished emotional response may be related to antidepressant dose, with higher doses being more likely to induce emotional blunting. Consequently, most clinicians either reduce the dose or switch to another drug when treating this symptom. Overall, more comprehensive clinical assessments or interviews specifically designed to evaluate antidepressant-induced emotional blunting in MDD patients are in need to elucidate the neuropsychological mechanisms behind this increasingly prevalent symptom.

Keywords: 5-HT; antidepressants; emotional blunting; major depressive disorder; treatment optimalization.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

Cited by

References

    1. James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. . Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. (2018) 392:1789–858. 10.1016/S0140-6736(18)32279-7 - DOI - PMC - PubMed
    1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. (2006) 3:e30442. 10.1371/journal.pmed.0030442 - DOI - PMC - PubMed
    1. Burcusa SL, Iacono WG. Risk for recurrence in depression. Clin Psychol Rev. (2007) 27:959–85. 10.1016/j.cpr.2007.02.005 - DOI - PMC - PubMed
    1. Thaipisuttikul P, Ittasakul P, Waleeprakhon P, Wisajun P, Jullagate S. Psychiatric comorbidities in patients with major depressive disorder. Neuropsychiatr Dis Treat. (2014) 10:2097–103. 10.2147/NDT.S72026 - DOI - PMC - PubMed
    1. American Psychiatric Association . Diagnostic Statistical Manual of Mental Disorders, 5th Edn. Washington, DC: American Psychiatric Association; (2013). Available online at: https://scholar.google.com/scholar_lookup?title=Diagnostic+and+Statistic... (accessed July 3, 2021).

LinkOut - more resources